Research Interests
- Pulmonary Arterial Hypertension
Board Certification and Academic Information
| Academic Departments |
Internal Medicine - Professor
|
| Academic Divisions |
Pulmonary
|
| Board Certification |
American Board of Internal Medicine (Sub: Pulmonary Disease)
American Board of Internal Medicine (Internal Medicine)
|
Academic Bio
Since July of 2007, Greg Elliott, M.D., M.A.C.P., has served as Chairman of the Department of Medicine at Intermountain Medical Center. In this position he is responsible for graduate medical education, continuing medical education, research and clinical care delivered at Intermountain Medical Center by more than 250 physicians who are board certified in internal medicine or relevant specialties of internal medicine. Prior to assuming these responsibilities, Dr. Elliott served as the Chief of the Pulmonary/Critical Care and Sleep Division at LDS Hospital.
A 1969 graduate of Brown University, Dr. Elliott earned his M.D. with honors from the University of Maryland School of Medicine. He completed his residency and chief medical residency at the University of Maryland hospitals and he completed fellowship training in pulmonary and critical care medicine at the University of Utah hospitals in 1978. After brief service on the faculty of the University of Maryland Medical School, Dr. Elliott returned to the University of Utah School of Medicine in 1980.
Shortly after returning to Utah, Dr. Elliott became the principal investigator of a NIH award to study primary pulmonary hypertension. He also directed research to advance the scientific basis for diagnosis, prevention, and treatment of venous thromboembolism. Known widely as an educator….. Dr. Elliott received numerous teaching awards, including the University of Utah School of Medicine Outstanding Faculty Award (1987).
From 1997 to 2001 he served as Governor of the Utah Chapter of the American College of Physicians, and in 2003 Dr. Elliott was awarded the honor of Master of the American College of Physicians.
Dr. Elliott has pursued research opportunities throughout his career. As an investigator he has authored or co-authored more than 100 peer-reviewed publications. He maintains an active research portfolio to advance understanding of pulmonary hypertension and venous thromboembolism. He continues to review manuscripts for leading peer reviewed scientific journals and he has served on the editorial board of CHEST since 2006. He also serves as a distinguished advisor to the scientific leadership council of the Pulmonary Hypertension Association.
Research Statement
My research aims to understand genotype and phenotype relationships as they relate to pulmonary arterial hypertension. I am particularly interested in advancing our understanding of pharmacogenomics and personalized medicine as they relate to the treatment of pulmonary arterial hypertension.
